国家公務員共済組合連合会 虎の門病院は、東京都港区虎ノ門二丁目にある病院である。設置者は国家公務員共済組合連合会。2次救急指定告示医療機関、臨床研修指定病院であると共に、東京都の肝疾患診療連携拠点病院に指定されている。

During the past decade, Toranomon Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 17 clinical trials were completed, i.e. on average, 51.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toranomon Hospital" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Merck Sharp & Dohme LLC" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "AbbVie" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toranomon Hospital" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Toranomon Hospital" are "Prostatic Neoplasms" (4 trials), "Breast Cancer" (3 trials), "Coronary Artery Disease" (3 trials), "Urinary Bladder Neoplasms" (3 trials) and "Angina Pectoris" (2 trials). Many other conditions were trialed in "Toranomon Hospital" in a lesser frequency.

Most popular intervention types in "Toranomon Hospital" are "Drug" (32 trials), "Biological" (8 trials), "Device" (6 trials), "Other" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Atezolizumab" (8 trials), "Pembrolizumab" (6 trials), "Docetaxel" (4 trials) and "Enzalutamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Toranomon Hospital" are 32 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Toranomon Hospital". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Toranomon Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Toranomon Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".